Immunofluorescent staining for p62 revealed a significantly higher number of cells expressing p62 in the kidneys of the CIS-treated Gal-3 wild-type mice then in the CIS-treated Gal-3 KO mice (Figure 6). The gene discussed is SQSTM1; the disease is in situ carcinoma.